By Dr Prem Premsrirut

How RNA interference and CRISPR/Cas9 technologies are helping to build better mouse models and push drug discovery into a new era.

By Professor Yvonne Perrie & Dr Euan Ramsay

Nanoparticles, and liposomes in particular, are growing in popularity as drug delivery vehicles for anti-cancer agents and inflammatory disease the...

By Dr Ellen L. Berg

Phenotypic screening is transforming drug discovery as advances are made in development of human-based physiologically-relevant in vitro systems.

By Dr Jason Mellad

The sequencing of the human genome in 2003 signalled the dawn of an exciting new era for genetic medicine. Yet almost 15 years later it has become ...

By Dr Philip Dubé

Inbred mice are critical tools in biomedical research and one particular strain, known as C57BL/6 (Black 6 or B6, for short), is rapidly becoming t...

By Dr Paul Shields

Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug deve...

Desktop Genetics Ltd, a company revolutionizing the way biologists use CRISPR genome editing technology, has today announced the launch of its DESK...

Irvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today anno...

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today...

Optibrium, a developer of software for small molecule drug discovery, has announced that it will join the Enhancing Translational Safety Assessment...

Avacta Group is pleased to announce it has initiated a research collaboration with FIT Biotech Oy to assess the effectiveness of developing gene th...

Desktop Genetics Ltd (DTG), a software company revolutionising the way biologists use CRISPR genome editing technology, and online investment platf...

Dates: 3-4 October 2017
Venue: Liverpool, UK

Dates: 17 October 2017
Venue: Dublin, Ireland

Dates: 11-15 November 2017
Venue: Washington DC, USA